PD-1 expression is linked to NK cell dysfunction and advanced liver fibrosis in HIV/HCV-coinfected individuals

被引:0
|
作者
Polo, M. L. [1 ]
Urioste, A. [1 ]
Gonzalez Polo, V. [1 ]
Poblete, G. [2 ]
Martinez, A. [2 ]
Sisto, A. [2 ]
Rolon, M. J. [2 ]
Turk, G. [1 ]
Laufer, N. [1 ,2 ]
机构
[1] INBIRS UBA CONICET, Buenos Aires, DF, Argentina
[2] Hosp Fernandez, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PDA0102
引用
收藏
页码:104 / 104
页数:1
相关论文
共 50 条
  • [31] How important is HIV therapy for preventing liver fibrosis progression in HIV-HCV-coinfected individuals?
    Rockstroh, Juergen Kurt
    ANTIVIRAL THERAPY, 2012, 17 (07) : 1223 - 1225
  • [32] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [33] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [34] Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data
    Berenguer, J.
    Bellon, J. M.
    Miralles, P.
    Alvarez, E.
    Sanchez-Conde, M.
    Cosin, J.
    Lopez, J. C.
    Alvarez, F.
    CatalaN, P.
    Resino, S.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (12) : 859 - 869
  • [35] Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
    Medrano, Luz Maria
    Berenguer, Juan
    Salguero, Sergio
    Gonzalez-Garcia, Juan
    Diez, Cristina
    Hontanon, Victor
    Garcia-Broncano, Pilar
    Ibanez-Samaniego, Luis
    Bellon, Jose M.
    Jimenez-Sousa, Maria Angeles
    Resino, Salvador
    FRONTIERS IN MEDICINE, 2021, 8
  • [36] Single Nucleotide Polymorphisms of CXCL9-11 Chemokines Are Associated With Liver Fibrosis in HIV/HCV-Coinfected Patients
    Pineda-Tenor, Daniel
    Berenguer, Juan
    Garcia-Alvarez, Monica
    Guzman-Fulgencio, Maria
    Carrero, Ana
    Aldamiz-Echevarria, Teresa
    Tejerina, Francisco
    Diez, Cristina
    Jimenez-Sousa, Maria A.
    Fernandez-Rodriguez, Amanda
    Munoz-Fernandez, Maria A.
    Resino, Salvador
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (04) : 386 - 395
  • [37] Association of serum lipid profile with liver fibrosis in HCV-coinfected HIV patients on suppressive anti-retroviral therapy
    Srisopa, Somkid
    Pipatsatitpong, Duangnate
    Akekawatchai, Chareeporn
    BIOMEDICAL REPORTS, 2024, 21 (04)
  • [38] Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients
    Vergara, Salvador
    Macias, Juan
    Mira, Jose A.
    Garcia-Garcia, Jose A.
    Merchante, Nicolas
    del Valle, Jose
    Abdel-Kader, Laila
    Lozano, Fernando
    Gomez-Mateos, Jesus M.
    Pineda, Juan A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) : 87 - 91
  • [39] Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes
    Maida, I.
    Martin-Carbonero, L.
    Sotgiu, G.
    Vispo, E.
    Barreiro, P.
    Gonzalez-Lahoz, J.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (12) : 866 - 871
  • [40] Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals
    Bavaro, Davide Fiore
    Saracino, Annalisa
    Fiordelisi, Deborah
    Bruno, Giuseppe
    Ladisa, Nicoletta
    Monno, Laura
    Angarano, Gioacchino
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (05) : 751 - 757